ENTITY
Bayer

Bayer (BAYN GR)

69
Analysis
Health CareGermany
Bayer AG produces and markets healthcare and agricultural products. The Company manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes.
more
bullishSillaJen Inc
25 Nov 2016 19:48

SillaJen IPO Part 4 - IPO Price & Post-IPO Risks

SillaJen IPO price was set at ₩15,000, the lowest end of the indicative price band, after conducting the demand survey from (Nov 23-24) the...

Logo
342 Views
Share
21 Nov 2016 20:42

Cadila Healthcare: Potential More than 30% Upside.

Cadila Healthcare Ltd (CDH IN) is the 4th largest pharmaceutical company in India and 9th largest generic drug company in the U.S. At FY 2018 P/E...

21 Nov 2016 17:59

MedTech as an Investment Theme

Medicine is changing. For hundreds of years, the key drivers of progress were biology and chemistry. Now they are data science and software.Big...

Logo
365 Views
Share
21 Nov 2016 07:45

Andrew on Tech: IOT Everywhere

The proliferation of IoT: With over 25% 5-year CAGR for IoT devices shipment and wafer foundry market but a very fragmented vendors list, we...

Logo
Andrew Lu
385 Views
Share
bullishSillaJen Inc
21 Nov 2016 05:33

SillaJen IPO Part 3 - Competitive Strengths of Product (Pexa-Vec)

* In Part 3 (as below), I summarized the competitive strengths of product (Pexa-Vec).SillaJen's Pexa-Vec is an advanced liver cancer treatment...

Logo
316 Views
Share
x